Related references
Note: Only part of the references are listed.Epigenetics in non-small cell lung cancer: from basics to therapeutics
Junaid Ansari et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Epigenomes as therapeutic targets
Christopher A. Hamm et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Quercetin Decreases Claudin-2 Expression Mediated by Up-Regulation of microRNA miR-16 in Lung Adenocarcinoma A549 Cells
Hiroyuki Sonoki et al.
NUTRIENTS (2015)
miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1)
Zhiyuan Han et al.
ONCOTARGET (2015)
Nuclear distribution of claudin-2 increases cell proliferation in human lung adenocarcinoma cells
Akira Ikari et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Reduced Expression of Claudin-2 is Associated with High Histological Grade and Metastasis of Feline Mammary Carcinomas
A. R. Flores et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2014)
1,3,4-Oxadiazole-Containing Histone Deacetylase Inhibitors: Anticancer Activities in Cancer Cells
Sergio Valente et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer.
Wen-yan Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
tert-Butylcarbamate-Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells
Sergio Valente et al.
CHEMMEDCHEM (2013)
Loss of Claudins 2 and 15 From Mice Causes Defects in Paracellular Na+ Flow and Nutrient Transport in Gut and Leads to Death from Malnutrition
Masami Wada et al.
GASTROENTEROLOGY (2013)
MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer
S. T. Guo et al.
ONCOGENE (2013)
Methylation of the Claudin 1 Promoter Is Associated with Loss of Expression in Estrogen Receptor Positive Breast Cancer
Francescopaolo Di Cello et al.
PLOS ONE (2013)
Fluid reabsorption in proximal convoluted tubules of mice with gene deletions of claudin-2 and/or aquaporin1
Jurgen Schnermann et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Increase in claudin-2 expression by an EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells
Akira Ikari et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia
Deepa Sampath et al.
BLOOD (2012)
Histone Deacetylases Activate Hepatocyte Growth Factor Signaling by Repressing MicroRNA-449 in Hepatocellular Carcinoma Cells
Reena Buurman et al.
GASTROENTEROLOGY (2012)
Expression of the Mammalian Target of Rapamycin Pathway Markers in Lung Adenocarcinoma and Squamous Cell Carcinoma
Hyun-Soo Kim et al.
PATHOBIOLOGY (2012)
Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells
Nguyen Thi Thuy Phuong et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer
Dan Li et al.
CLINICAL CANCER RESEARCH (2011)
Predicted expansion of the claudin multigene family
Katsuhiko Mineta et al.
FEBS LETTERS (2011)
Claudin-2 knockdown decreases matrix metalloproteinase-9 activity and cell migration via suppression of nuclear Sp1 in A549 cells
Akira Ikari et al.
LIFE SCIENCES (2011)
Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes
S. Tabaries et al.
ONCOGENE (2011)
Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation
P. Dhawan et al.
ONCOGENE (2011)
Claudins and tricellulin in fibrolamellar hepatocellular carcinoma
Attila Patonai et al.
VIRCHOWS ARCHIV (2011)
Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry
Maria Berdasco et al.
DEVELOPMENTAL CELL (2010)
Molecular Basis of the Core Structure of Tight Junctions
Mikio Furuse
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
HDAC expression and clinical prognosis in human malignancies
Wilko Weichert
CANCER LETTERS (2009)
Akt-dependent and -independent mechanisms of mTOR regulation in cancer
Regan M. Memmott et al.
CELLULAR SIGNALLING (2009)
Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues
Junming Guo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
NF-κB: A Key Player in Lung Cancer
[Anonymous]
CELL (2009)
Silencing of Claudin-11 Is Associated with Increased Invasiveness of Gastric Cancer Cells
Rachana Agarwal et al.
PLOS ONE (2009)
Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma
Etienne Meylan et al.
NATURE (2009)
Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non-Small Cell Lung Cancer (Publication with Expression of Concern. See vol. 26, pg. 2768, 2020)
Arnaud Van Den Broeck et al.
CLINICAL CANCER RESEARCH (2008)
Tight junction-based epithelial microenvironment and cell proliferation
S. Tsukita et al.
ONCOGENE (2008)
Hypermethylation-modulated downregulation of claudin-7 expression promotes the progression of colorectal carcinoma
Fumihito Nakayama et al.
PATHOBIOLOGY (2008)
Global histone modifications predict prognosis of resected non-small-cell lung cancer
Fabrice Barlesi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Expression of Cdx2 and claudin-2 in the multistage tissue of gastric carcinogenesis
Song Xin et al.
ONCOLOGY (2007)
Nuclear factor-κB (NF-κB) is frequently expressed in lung cancer and preneoplastic lesions
Ximing Tang et al.
CANCER (2006)
Claudin-1 and claudin-2 differentiate fetal and embryonal components in human hepatoblastoma
J Halasz et al.
HUMAN PATHOLOGY (2006)
Signalling to and from tight junctions
K Matter et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Multifunctional strands in tight junctions
S Tsukita et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Share Paper
